Clinical Trials Directory

Trials / Completed

CompletedNCT06252428

Detection of Biofilm Among Uropathogenic Escherichia Coli Clinical Isolates in Suez Canal University Hospitals

Status
Completed
Phase
Study type
Observational
Enrollment
47 (actual)
Sponsor
Suez Canal University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This descriptive cross-sectional study will beconducted in Suez Canal University Hospitals (SCUHs) in Ismailia, Egypt. The study aims to detect Escherichia coli biofilm producers to improve prognosis and treatment and reduce morbidity and mortality rates due to this infection.

Detailed description

Forty seven clinical isolates of non-duplicated UPEC will be collected from clinically suspected cases of UTI in different departments in SCUHs. Isolates will be identified as E. coli by colony morphology, Gram staining and biochemical reactions. Antimicrobial sensitivity testing will be performed by Kirby-Bauer disc diffusion method on Muller-Hinton agar plate. The detection of biofilm will be carried out by Congo Red Agar (CRA) method and modified tissue culture plate (MTCP) method.

Conditions

Timeline

Start date
2022-12-20
Primary completion
2024-02-01
Completion
2024-02-20
First posted
2024-02-09
Last updated
2024-03-05

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06252428. Inclusion in this directory is not an endorsement.

Detection of Biofilm Among Uropathogenic Escherichia Coli Clinical Isolates in Suez Canal University Hospitals (NCT06252428) · Clinical Trials Directory